Zhejiang Venom Biotechnology Co., Ltd.

A high-tech enterprise focused on the biopharmaceutical and medical aesthetics sectors, specializing in the development of snake venom enzymes and peptide raw materials

As an innovative enterprise under the investment and control of Jiaxing Changsheng Agricultural Development Co., Ltd., Venom Biotechnology has become a pioneer in the industry by leveraging its first-mover advantage in the field of snake-derived biopharmaceuticals and healthcare. The company is deeply committed to developing the medicinal value of snake-derived biological resources, with its R&D scope covering multiple key areas: from anti-tumor drug research utilizing active components of snake venom, to the development of innovative therapies for cardiovascular and cerebrovascular diseases, and extending to the application of snake-derived traditional Chinese medicinal materials in the health and wellness sector, forming a complete industrial chain that spans disease treatment and health maintenance.

Looking to the future, Venom Bio will further expand its technological boundaries, focusing on cutting-edge biotechnology fields such as protein modification and the efficient expression of recombinant proteins, and will fully advance the R&D process for novel recombinant proteins and peptide drugs. At the same time, the company will also initiate clinical research in nucleic acid-based biotechnology, aiming to provide more efficient and safer solutions for the treatment of major diseases through synergistic innovation across multiple technological pathways, and to continue leading technological innovation and industrial upgrading in the snake-derived biopharmaceutical industry.